[Clinical study on the action of FC 35 a A (new combination of clorazepate dipotassium, codeine and paracetamol) in obstetric and gynecologic pain].
D000082:Acetaminophen / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000698:Analgesia / Q000379:methods*; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D003009:Clorazepate Dipotassium / Q000009:adverse effects / Q000627:therapeutic use*; D003061:Codeine / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D014594:Uterine Neoplasms / Q000150:complications*
D014151:Anti-Anxiety Agents; D004338:Drug Combinations; D000082:Acetaminophen; D003009:Clorazepate Dipotassium; D003061:Codeine
Studio clinico sull'attività di FC 35 a A (nuova associazione di clorazepato dipotassico, codeina e paracetamolo) in manifestazioni algiche di interesse ostetrico-ginecologico.